The Utility of Anatomical Liver Resection in Hepatocellular Carcinoma: Associated with Improved Outcomes or Lack of Supportive Evidence?

por Ju, Michelle, Yopp, Adam C.
Publicado 2019

Evolving thresholds for liver transplantation in hepatocellular carcinoma: A Western experience

por Ju, Michelle R., Yopp, Adam C.
Publicado 2020

Challenging the Treatment Paradigm: Selecting Patients for Surgical Management of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus

por Nevarez, Nicole M, Yopp, Adam C
Publicado 2021

Primary Gastric Melanoma: Case Report of a Rare Malignancy

por Augustyn, Alexander, de Leon, Emma Diaz, Yopp, Adam C.
Publicado 2015

Extrahepatic metastasis risk of hepatocellular carcinoma based on α-fetoprotein and tumor staging parameters at cross-sectional imaging

por Yokoo, Takeshi, Patel, Amish D, Lev-Cohain, Naama, Singal, Amit G, Yopp, Adam C, Pedrosa, Ivan
Publicado 2017

Rare Hepatic Arterial Anatomic Variants in Patients Requiring Pancreatoduodenectomy and Review of the Literature

por Ramanadham, Smita, Toomay, Seth M., Yopp, Adam C., Balch, Glen C., Sharma, Rohit, Schwarz, Roderich E., Mansour, John C.
Publicado 2012

Mitotic regulators and the SHP2-MAPK pathway promote IR endocytosis and feedback regulation of insulin signaling

por Choi, Eunhee, Kikuchi, Sotaro, Gao, Haishan, Brodzik, Karolina, Nassour, Ibrahim, Yopp, Adam, Singal, Amit G., Zhu, Hao, Yu, Hongtao
Publicado 2019

Correlative studies of a Phase II clinical study of bavituximab and sorafenib in patients with advanced hepatocellular carcinoma

por Yopp, Adam, Kallinteris, Nikoletta, Huang, Xianming, Shan, Joe, Menander, Kerstin, Hutchins, Jeff, King, Steve, Xu, Xiaowei, Gabrilovich, Dmitry, Brekken, Rolf
Publicado 2014

Antibody-mediated blockade of phosphatidylserine enhances the anti-tumor activity of targeted therapy and immune checkpoint inhibitors by affecting myeloid and lymphocyte populatio...

por Yopp, Adam, Kallinteris, Nikoletta, Huang, Xianming, Shan, Joe, Menander, Kerstin, Freimark, Bruce, Hutchins, Jeff, King, Steve, Gabrilovich, Dmitry I, Brekken, Rolf
Publicado 2014

Cefoxitin versus piperacillin–tazobactam as surgical antibiotic prophylaxis in patients undergoing pancreatoduodenectomy: protocol for a randomised controlled trial

por Nevarez, Nicole M, Brajcich, Brian C, Liu, Jason, Ellis, Ryan, Ko, Clifford Y, Pitt, Henry A, D'Angelica, Michael I, Yopp, Adam C
Publicado 2021

Hepatocellular Carcinoma Screening Process Failures in Patients with Cirrhosis

por Marquardt, Patrick, Liu, Po‐Hong, Immergluck, Joshua, Olivares, Jocelyn, Arroyo, Ana, Rich, Nicole E., Parikh, Neehar D., Yopp, Adam C., Singal, Amit G.
Publicado 2021

Pain Management After Open Liver Resection: Epidural Analgesia Versus Ultrasound-Guided Erector Spinae Plane Block

por Stewart, Jesse W, Yopp, Adam, Porembka, Matthew R, Karalis, John D, Sunna, Mary, Schulz, Cedar, Alexander, John C, Gasanova, Irina, Joshi, Girish P
Publicado 2022

New method for immunoprofiling of the tumor microenvironment of cancer patients by opal multiplex quantitative immunofluorescence (IF) assay

por Kallinteris, Nikoletta L, Shan, Joseph, Meyer, Jeffrey, Yopp, Adam C, Frankel, Athur, Downing, Sean R, Robertson, Brenda S, Hoyt, Cliff, King, Steven, Bifulco, Carlo, Ballesteros-Merino, Carmen, Fox, Bernard
Publicado 2015

Tumor suppression by miR-26 overrides potential oncogenic activity in intestinal tumorigenesis

por Zeitels, Lauren R., Acharya, Asha, Shi, Guanglu, Chivukula, Divya, Chivukula, Raghu R., Anandam, Joselin L., Abdelnaby, Abier A., Balch, Glen C., Mansour, John C., Yopp, Adam C., Richardson, James A., Mendell, Joshua T.
Publicado 2014

Multidisciplinary care for patients with HCC: a systematic review and meta-analysis

por Seif El Dahan, Karim, Reczek, Annika, Daher, Darine, Rich, Nicole E., Yang, Ju Dong, Hsiehchen, David, Zhu, Hao, Patel, Madhukar S., Bayona Molano, Maria del Pilar, Sanford, Nina, Gopal, Purva, Parikh, Neehar D., Yopp, Adam C., Singal, Amit G.
Publicado 2023

Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets

por Witkiewicz, Agnieszka K., McMillan, Elizabeth A., Balaji, Uthra, Baek, GuemHee, Lin, Wan-Chi, Mansour, John, Mollaee, Mehri, Wagner, Kay-Uwe, Koduru, Prasad, Yopp, Adam, Choti, Michael A., Yeo, Charles J., McCue, Peter, White, Michael A., Knudsen, Erik S.
Publicado 2015

Lenvatinib inhibits the growth of gastric cancer patient-derived xenografts generated from a heterogeneous population

por Karalis, John D., Yoon, Lynn Y., Hammer, Suntrea T. G., Hong, Changjin, Zhu, Min, Nassour, Ibrahim, Ju, Michelle R., Xiao, Shu, Castro-Dubon, Esther C., Agrawal, Deepak, Suarez, Jorge, Reznik, Scott I., Mansour, John C., Polanco, Patricio M., Yopp, Adam C., Zeh, Herbert J., Hwang, Tae Hyun, Zhu, Hao, Porembka, Matthew R., Wang, Sam C.
Publicado 2022